South Korea
· Delayed Price · Currency is KRW Shinpoong Pharmaceutical Co.,Ltd Statistics
Total Valuation
Shinpoong Pharmaceutical Co.,Ltd has a market cap or net worth of KRW 571.11 billion. The enterprise value is 558.53 billion.
| Market Cap | 571.11B |
| Enterprise Value | 558.53B |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Shinpoong Pharmaceutical Co.,Ltd has 51.26 million shares outstanding. The number of shares has decreased by -2.37% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 51.26M |
| Shares Change (YoY) | -2.37% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.62% |
| Owned by Institutions (%) | 5.06% |
| Float | 34.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.67 |
| PB Ratio | 2.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.42 |
| EV / Sales | 2.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -16.74 |
Financial Position
The company has a current ratio of 2.80, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.80 |
| Quick Ratio | 1.99 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.36 |
| Interest Coverage | -12.56 |
Financial Efficiency
Return on equity (ROE) is -15.02% and return on invested capital (ROIC) is -5.83%.
| Return on Equity (ROE) | -15.02% |
| Return on Assets (ROA) | -5.36% |
| Return on Capital (ROIC) | -5.83% |
| Revenue Per Employee | 252.14M |
| Profits Per Employee | -50.28M |
| Employee Count | 828 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.47 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.28% in the last 52 weeks. The beta is 0.81, so Shinpoong Pharmaceutical Co.,Ltd's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | -15.28% |
| 50-Day Moving Average | 12,002.60 |
| 200-Day Moving Average | 12,829.30 |
| Relative Strength Index (RSI) | 39.26 |
| Average Volume (20 Days) | 162,649 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shinpoong Pharmaceutical Co.,Ltd had revenue of KRW 208.78 billion and -41.63 billion in losses. Loss per share was -812.13.
| Revenue | 208.78B |
| Gross Profit | 79.43B |
| Operating Income | -30.83B |
| Pretax Income | -39.41B |
| Net Income | -41.63B |
| EBITDA | -18.75B |
| EBIT | -30.83B |
| Loss Per Share | -812.13 |
Balance Sheet
The company has 59.08 billion in cash and 45.23 billion in debt, giving a net cash position of 13.85 billion or 270.11 per share.
| Cash & Cash Equivalents | 59.08B |
| Total Debt | 45.23B |
| Net Cash | 13.85B |
| Net Cash Per Share | 270.11 |
| Equity (Book Value) | 268.68B |
| Book Value Per Share | 5,216.65 |
| Working Capital | 124.92B |
Cash Flow
In the last 12 months, operating cash flow was -26.49 billion and capital expenditures -6.87 billion, giving a free cash flow of -33.36 billion.
| Operating Cash Flow | -26.49B |
| Capital Expenditures | -6.87B |
| Free Cash Flow | -33.36B |
| FCF Per Share | -650.70 |
Margins
Gross margin is 38.05%, with operating and profit margins of -14.76% and -21.05%.
| Gross Margin | 38.05% |
| Operating Margin | -14.76% |
| Pretax Margin | -18.88% |
| Profit Margin | -21.05% |
| EBITDA Margin | -8.98% |
| EBIT Margin | -14.76% |
| FCF Margin | -15.98% |
Dividends & Yields
Shinpoong Pharmaceutical Co.,Ltd does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.37% |
| Shareholder Yield | 2.37% |
| Earnings Yield | -7.46% |
| FCF Yield | -5.98% |
Stock Splits
The last stock split was on December 29, 2014. It was a forward split with a ratio of 1.040008.
| Last Split Date | Dec 29, 2014 |
| Split Type | Forward |
| Split Ratio | 1.040008 |
Scores
Shinpoong Pharmaceutical Co.,Ltd has an Altman Z-Score of 7.09.
| Altman Z-Score | 7.09 |
| Piotroski F-Score | n/a |